Oral hypoglycemic agents for gestational diabetes mellitus?

Author： Maymone Ana Cristina Baillargeon Jean-Patrice Méénard Julie Ardilouze Jean-Luc

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.10, Iss.2, 2011-03, pp. : 227-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetics of Gestational Diabetes Mellitus

Current Medicinal Chemistry, Vol. 14, Iss. 5, 2007-02 ,pp. : 569-583

Bentham Science Publishers

Access to resources Recommend Favorite

Oral Antidiabetic Agents: Current Role in Type 2 Diabetes Mellitus

By Krentz Andrew J.

Drugs, Vol. 65, Iss. 3, 2005-01 ,pp. : 385-411

Adis International

Access to resources Recommend Favorite

Cost-effectiveness of oral hypoglycaemic agents for the treatment of type 2 diabetes mellitus

By Ward Alexandra O’Brien Judith A Salas Maribel

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 4, 2005-04 ,pp. : 601-608

Informa Healthcare

Access to resources Recommend Favorite

Management of gestational diabetes mellitus discussed

Inpharma, Vol. 1, Iss. 1317, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Impact of Seasonality on Gestational Diabetes Mellitus

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 17, Iss. 3, 2017-10 ,pp. : 246-252

Bentham Science Publishers

Access to resources Recommend Favorite